NCT04884971View on ClinicalTrials.gov

Microbiota Transplant Therapy for Pulmonary Arterial Hypertension: Early Safety and Feasibility Study

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Intestinal microbiota transplant (IMT)

Two size 00 capsules from a single lot will be taken daily. Approximately 2.0 x 10\^11 bacteria from a healthy donor are contained in each capsule.

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT04884971 - Microbiota Transplant Therapy for Pulmonary Arterial Hypertension: Early Safety and Feasibility Study | Biotech Hunter | Biotech Hunter